510(k) · Cleared
ClearedHippocampe Marathon and Trail
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Vipamat Sarl · IQC Wheelchair, Special Grade
Cleared on Jun 23, 2025 as substantially equivalent to K051709 (Vipamat Technologie, 2005) after a 32-day review. Its family tree reaches back 4 generations to 1992.
- Decided
- Jun 23, 2025
- Review
- 32 days
- Class
- Class II
- Product code
- IQC
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 4 generations to K915262 (1992). 7 ancestors in all. No later device cites it as a predicate yet.
- Root · 4 generations backK915262 Bantex Brand WheelchairsBantex Corp. · 1992
- 3 generations backK982607 Manual WheelchairG. Hirsch and Co., Inc. · 1998
- 2 generations backK031910 Stainless Steel Aquatic WheelchairDb Perks & Associates, Ltd. · 2003
- 1 generation backK051709 Hippocampe WheelchairVipamat Technologie · 2005
- This deviceK251570 Hippocampe Marathon and TrailVipamat Sarl · 2025
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K915262 | Bantex Brand Wheelchairs | Bantex Corp. | 1992 | — |
| −3 | K982607 | Manual Wheelchair | G. Hirsch and Co., Inc. | 1998 | — |
| −2 | K031910 | Stainless Steel Aquatic Wheelchair | Db Perks & Associates, Ltd. | 2003 | — |
| −1 | K051709 | Hippocampe Wheelchair | Vipamat Technologie | 2005 | — |
| 0 (this device) | K251570 | Hippocampe Marathon and Trail | Vipamat Sarl | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 2003 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in IQC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K051709 | Hippocampe WheelchairSummary page 5…21 CFR 807.92(a)(3) Predicate # Predicate Trade Name (Primary Predicate is listed first) Product Code I K051709 Hippocampe Wheelchair IQC Device Descript… | 2005 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 33 years and passes through 5 companies; a new generation was cleared every 6.6 years on median.
- None of the 7 ancestors has a recall.
- 1 other device also cites its predicate K051709.
How does its category compare?
All IQC devicesIQC Wheelchair, Special Grade: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.
FDA decisions per year · IQC
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · IQC
Too few IQC 510(k)s in any year since 2007 to give a median.
Recalls per year · IQC
No recall names IQC since 2007.
Adverse event reports per year · IQC
No MAUDE report names IQC since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 1 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 1 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Hippocampe Marathon and Trail is indicated to provide mobility to persons restricted to a seated position on various terrains, including footpaths and trails.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K251570 · printed Nov 6, 2026
Cite this page
510(k) Report. “K251570: Hippocampe Marathon and Trail.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K251570
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026